SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Global challenges for women with ovarian cancer
Fri Oct 19th - Most women with ovarian cancer had never heard of the disease before they were diagnosed, a global study has revealed. More
Women face more chemotherapy side-effects
Fri Oct 19th - Women being treated for oesophageal and stomach cancer may experience certain chemotherapy side-effects more often than men, according to analysis published last night. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OTHER NEWS FEEDS OF INTEREST
HEALTHY EATING BOOKS
ENGLEMED HEALTH NEWS

Hope for anti-inflammatories for heart

Wednesday May 16th, 2018

Senior cardiologists have set out their views on the relationship between hypercholesterolaemia and inflammation in atherosclerosis.

The European Society of Cardiology statement, released on Monday (14 May) in the European Journal of Preventive Cardiology, explains that dyslipidaemia and inflammation are closely connected in the development of atherosclerosis.

It states: "In fact, low density lipoprotein-lowering drugs have anti-inflammatory effects."

In the light of a recent study on anti-inflammatory drugs and cardiovascular events, showing a potential beneficial effect, the experts say: "These data confirm the connection between lipids and inflammation."

Specifically, lipids activate a receptor protein called 3 inflammasome, leading to interleukin-1 beta activation, they write. So the combination of low-density lipoprotein-lowering drugs and anti-inflammatory drugs could further decrease the risk of cardiovascular events.

"However," the experts warn, "both therapies are not at the same level, given the large evidence showing that low-density lipoprotein-lowering drugs reduce cardiovascular risk as opposed to only one randomised trial of interleukin-1 beta blockade."

They call for further studies involving a wider patient group, and gauging the risk of developing fatal infections and sepsis with anti-inflammatory therapies.

First author of the statement, Dr Jose Tunon of the University Hospital Fundacion Jimenez Diaz, Spain, says: "We are on the cusp of a new era in cardiovascular disease prevention. The basis of protection against cardiovascular disease will continue to be a healthy lifestyle, including not smoking, being physically active, and eating healthy food.

“In addition, several drugs such as lipid-lowering medication and antithrombotic therapies have proven to be useful in the prevention of cardiovascular events.

"With further evidence, anti-inflammatory drugs could become one more tool in the treatment of atherosclerosis."

Tunon, J. et al. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice. European Journal of Preventive Cardiology 14 May 2018 doi: 10.1177/2047487318773384

http://journals.sagepub.com/doi/full/10.1177/2047487318773384

Tags: Europe | Heart Health | Pharmaceuticals

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES